Trials / Active Not Recruiting
Active Not RecruitingNCT00568997
10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
A Prospective 10 Year Observational Registry of Pediatric Subjects (Age Greater Than or Equal to Two Years to Age Less Than or Equal to 17 Years) With Atopic Dermatitis Who Have Used Elidel Cream 1% (Pimecrolimus)
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 8,000 (estimated)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 2 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.
Detailed description
Registry study to examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pimecrolimus | Pimecrolimus 1% cream |
Timeline
- Start date
- 2005-06-27
- Primary completion
- 2027-12-01
- Completion
- 2028-06-01
- First posted
- 2007-12-06
- Last updated
- 2025-09-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00568997. Inclusion in this directory is not an endorsement.